On January 23, 2024, DaShenLin Pharmaceutical Group Co., Ltd. cancelled the transaction. The transaction has been approved by Shangai Stock exchange.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.6 CNY | +1.89% | -1.95% | -13.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.25% | 3.4B | |
-30.56% | 11.21B | |
-30.19% | 6.23B | |
+7.42% | 6B | |
-10.01% | 5.89B | |
-0.73% | 4.72B | |
+53.60% | 4.32B | |
-9.42% | 3.77B | |
-5.84% | 3.03B | |
-2.20% | 2.78B |
- Stock Market
- Equities
- 603233 Stock
- News DaShenLin Pharmaceutical Group Co., Ltd.
- DaShenLin Pharmaceutical Group Co., Ltd. cancelled the transaction announced on January 19, 2023